Proteomics

Dataset Information

0

PD1 inhibits PKCθ-dependent phosphorylation of cytoskeleton-related proteins and immune synapse formation


ABSTRACT: The cell surface receptor programmed death 1 (PD1) is a major target for antibody-based cancer immunotherapies. An improved understanding of intracellular pathways targeted by PD1 is needed to develop better predictive and prognostic biomarkers. Here, via unbiased phosphoproteome analysis of primary human T cells, we demonstrate that PD1 triggering reduces the phosphorylation and physical association with PKC theta of a variety of cytoskeletal proteins. TCR-induced phosphorylation of Vimentin, a cytoskeleton protein identified as a PKC theta target and binding partner in our study, was found to be long-lasting and durably inhibited by PD1 triggering, and Vimentin phosphorylation inversely correlated with PDL1 levels in intratumoral T cells in human lung carcinoma. Thus, PKCθ and its substrate Vimentin represent important targets of PD1-mediated T cell inhibition and low levels of Vimentin phosphorylation could be considered as a biomarker indicating PD1 pathway engagement.

INSTRUMENT(S): Orbitrap Fusion, Q Exactive Plus

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Cell, Blood

SUBMITTER: Manfredo Quadroni  

LAB HEAD: Margot Thome

PROVIDER: PXD044028 | Pride | 2024-04-19

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
190711_Chmiest_11457_I1.raw Raw
190711_Chmiest_11457_I2.raw Raw
190711_Chmiest_11458_I1.raw Raw
190711_Chmiest_11458_I2.raw Raw
190716_Chmiest_11457_phospho-10.raw Raw
Items per page:
1 - 5 of 22

Similar Datasets

2010-05-25 | E-GEOD-11968 | biostudies-arrayexpress
2015-03-06 | E-GEOD-59792 | biostudies-arrayexpress
2020-03-19 | PXD014318 | Pride
2015-12-01 | PXD003258 | Pride
2020-04-14 | PXD013757 | Pride
2017-03-16 | PXD006078 | Pride
2024-07-25 | PXD050625 | Pride
2022-02-23 | PXD027228 | Pride
2008-06-11 | E-GEOD-9771 | biostudies-arrayexpress
2015-12-10 | E-GEOD-75830 | biostudies-arrayexpress